The customer relationship management company is experiencing slower growth, and investors are concerned.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA17 Aug 2025, 19:45 UTC
AI-generated source summary
The video analyzes Salesforce (CRM) stock, currently trading at $233.37 near its 52-week low of $226. The analyst uses revenue growth from 2016 to 2025, showing an increase from $8.4 billion to $38.6 billion (a CAGR of 20.2%), but expects this growth to decelerate. He expresses concern about Salesforce's acquisition strategy, noting overpayment for past acquisitions. The operating margin has improved to 20.5%, a tenfold increase from 2021, and the return on invested capital has risen to 7.2%. The analyst shares his discounted cash flow valuation, setting a fair value of $278.88 per share. Considering forward P/E, the stock is undervalued. He acknowledges risks including slowing growth and potential poor acquisitions. The recommendation for CRM is a buy.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.